GITNUXSOFTWARE ADVICE
Biotechnology PharmaceuticalsTop 10 Best CRO Pharma Services of 2026
Ranked CRO list of cro pharma services providers for trial outsourcing. IQVIA, ICON, and Parexel are compared with criteria and tradeoffs.
How we ranked these tools
Core product claims cross-referenced against official documentation, changelogs, and independent technical reviews.
Analyzed video reviews and hundreds of written evaluations to capture real-world user experiences with each tool.
AI persona simulations modeled how different user types would experience each tool across common use cases and workflows.
Final rankings reviewed and approved by our editorial team with authority to override AI-generated scores based on domain expertise.
Score: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page — this does not influence rankings. Editorial policy
IQVIA is the best fit for global pharma programs that want analytics-driven CRO execution with operational rigor, whereas CROMSOURCE is the better alternative when you need dependable end-to-end trial execution and coordination support.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
IQVIA
Real-world evidence execution with integrated healthcare data, analytics, and operational study support
Built for global pharma programs needing analytics-driven CRO execution and operational rigor.
ICON
Editor pickIntegrated clinical operations plus data management execution under one delivery structure
Built for sponsors needing disciplined global clinical operations and data delivery support.
Parexel
Editor pickIntegrated end-to-end trial delivery with centralized quality and regulatory documentation workflows
Built for large programs needing full-service CRO execution and regulatory-ready outputs.
Related reading
Comparison Table
IQVIA
enterprise_vendorProvides biopharma clinical development, real-world evidence analytics, regulatory support, and quality and compliance consulting for life science programs.
Real-world evidence execution with integrated healthcare data, analytics, and operational study support
IQVIA stands out for large-scale real-world evidence and healthcare analytics execution tied to global pharma workflows. Its Cro Pharma Services capabilities center on data strategy, end-to-end study support, and operations that connect clinical, commercial, and outcomes insights.
Teams can leverage advanced analytics, therapeutic expertise, and CRO-style delivery controls for complex, multi-region programs. Engagement quality is typically strongest for organizations needing rigorous data handling and consistent operational governance across study stages.
- +Global real-world evidence programs with structured data pipelines for pharma decisions
- +End-to-end CRO delivery support across study execution and operational governance
- +Therapeutic and method expertise for complex protocol and data requirements
- +Strong linkage of clinical insights with downstream outcomes and analytics
- –Requires formal coordination across stakeholders for smooth study operations
- –Complex governance can slow changes during late-stage study adjustments
- –Best results depend on high-quality source data inputs
- –Not optimized for teams seeking lightweight, low-touch CRO engagement
Global RWE and data science teams
Multi-country observational study data pipeline build
Faster study execution and fewer rework
Clinical operations and trial managers
End-to-end support for multi-region trials
Improved protocol adherence across sites
Show 2 more scenarios
Commercial and outcomes analytics teams
Linking patient outcomes to market insights
Better market and access planning
Connects outcomes signals with commercial decision inputs using healthcare analytics and reporting.
Pharma data governance and compliance teams
Standardized data strategy and controls
Lower compliance risk
Implements data handling standards that reduce risk across clinical, commercial, and outcomes datasets.
Best for: Global pharma programs needing analytics-driven CRO execution and operational rigor
More related reading
ICON
enterprise_vendorSupports biopharmaceutical development with end-to-end clinical operations, regulatory services, and pharmacovigilance delivery.
Integrated clinical operations plus data management execution under one delivery structure
ICON stands out for end-to-end clinical trial execution support, including project management, site engagement, and data delivery across therapeutic areas. Cro Pharma Services teams commonly rely on ICON for scalable operational oversight of study timelines, investigator communications, and quality-controlled trial processes.
ICON’s core capabilities typically include clinical monitoring, regulatory documentation support, and robust data management and reporting aligned to protocol requirements. This makes ICON a strong fit for organizations that need reliable global delivery and disciplined execution across complex protocols.
- +Proven global trial operations support with consistent site and vendor coordination
- +Strong clinical monitoring coverage for protocol adherence and issue escalation
- +Structured data management and reporting workflows that support timely decisions
- +Regulatory document handling that fits protocol and compliance expectations
- –Operational coordination can add overhead for teams with limited internal trial staff
- –Complex governance requirements can slow changes to study plans
- –Specialized support often depends on study scope and regional execution model
Sponsor program managers
Oversee global site start-up and timelines
Fewer start-up delays
Regulatory affairs teams
Assemble submissions and protocol documentation
Cleaner submission packages
Show 2 more scenarios
Clinical data and BI analysts
Validate trial data and reporting outputs
On-time analysis datasets
ICON manages data handling and reporting so analysis-ready datasets match protocol-defined endpoints and schedules.
Medical monitor governance leads
Maintain disciplined oversight during monitoring
Improved protocol adherence
ICON supports monitoring execution and investigator interactions to uphold protocol compliance and quality standards.
Best for: Sponsors needing disciplined global clinical operations and data delivery support
Parexel
enterprise_vendorProvides clinical development services, medical writing, regulatory strategy, and pharmacovigilance for pharmaceutical and biotechnology companies.
Integrated end-to-end trial delivery with centralized quality and regulatory documentation workflows
Parexel stands out with deep clinical development operations across global phases and therapeutic areas. The CRO capabilities cover protocol and study planning, site and patient management, and end-to-end data and regulatory support.
Cro Pharma Services teams benefit from Parexel’s proven delivery model for complex trials that need coordinated cross-functional execution. Clinical quality, monitoring rigor, and document generation support smoother submissions and consistent study conduct.
- +Global trial operations with structured, repeatable study execution processes
- +Comprehensive clinical services from planning to regulatory-facing deliverables
- +Experienced monitoring approach that supports study quality and continuity
- +Cross-functional support covering sites, data, and documentation activities
- –Implementation coordination demands strong client governance and clear decision timelines
- –Program customization can require more upfront alignment and requirements gathering
- –Geographic complexity may slow changes when multiple sites are activated
Clinical operations directors
Global phase trial site enablement
Faster enrollment readiness
Regulatory affairs leads
Coordinated submission document generation
More submission consistency
Show 2 more scenarios
Biostatistics and data teams
End-to-end data integration and support
Cleaner analysis datasets
Operational data processes align clinical conduct with analysis-ready datasets.
Program management offices
Cross-functional execution across phases
Lower operational risk
Delivery model coordinates protocol planning through monitoring and data operations.
Best for: Large programs needing full-service CRO execution and regulatory-ready outputs
CROMSOURCE
specialistOffers flexible clinical trial execution, investigator support, and regulatory-adjacent operational services for biotechnology and pharma teams.
Study deliverables and progress reporting workflow supporting sponsor visibility
CROMSOURCE stands out for delivering CRO Pharma Services with strong operational focus on study execution and sponsor alignment. The core capabilities emphasize end-to-end clinical trial support across protocol setup, monitoring support, and site coordination workflows.
CROMSOURCE also supports documentation rigor by managing practical outputs like study deliverables and progress reporting for stakeholders. This service profile fits teams that need consistent trial process handling rather than only isolated consulting work.
- +Strong study execution processes for CRO Pharma Services and sponsor alignment
- +Practical site coordination support helps keep enrollment activities moving
- +Documentation and deliverable management supports consistent stakeholder reporting
- –Less clarity on specialized therapeutic niches beyond general CRO execution
- –Monitoring depth details are not always explicit for complex study designs
- –Engagement fit may be weaker for teams needing highly bespoke analytics
Best for: Sponsors needing reliable end-to-end CRO execution and coordination support
Syneos Health
enterprise_vendorDelivers clinical development and commercialization services including clinical operations, regulatory support, and medical communications for pharma sponsors.
End-to-end clinical operations tied to commercialization and medical affairs execution
Syneos Health stands out for combining full-service clinical operations with commercialization execution under one delivery structure for Cro Pharma Services needs. The organization supports end-to-end drug development and lifecycle work that can cover protocol-driven clinical trials through post-approval market execution.
It also brings specialized capabilities in biostatistics, data management, and medical affairs support to align evidence generation with launch and brand strategy. For CRO program execution, the depth of cross-functional resourcing helps manage sponsor requirements spanning study start-up, conduct, and reporting.
- +Integrated clinical and commercialization delivery under one vendor model
- +Strength in clinical operations, including start-up, conduct, and close-out
- +Data management and biostatistics capabilities support analysis-ready datasets
- +Medical affairs support helps connect evidence to prescribing needs
- –Enterprise-scale delivery can feel less flexible for small or narrow studies
- –Governance processes may add overhead for rapid, iterative change requests
- –Coordination across multiple functional groups can increase handoff workload
- –Specialization breadth may require careful scope definition for niche programs
Best for: Sponsors needing integrated clinical and lifecycle execution across therapeutic programs
Wuxi AppTec
enterprise_vendorProvides integrated preclinical, clinical, and lab-to-clinic development services for biologics and pharmaceutical programs.
End-to-end small-molecule and biologics development with IND-enabling and clinical supply support
Wuxi AppTec stands out for delivering end-to-end pharmaceutical development services across discovery, preclinical, and clinical operations. Core capabilities cover small-molecule and biologics workflows, including synthesis, analytical testing, and bioanalytical method development.
Delivery is strengthened by integrated translational services that support IND-enabling studies and clinical trial material management. Operations fit programs that need scalable lab throughput and standardized cross-site execution.
- +Integrated discovery-to-clinical delivery reduces handoff friction across functional teams
- +Strong analytical and bioanalytical services support method development and validation
- +Clinical trial material and study execution capacity supports multi-site timelines
- –Complex programs require upfront alignment on specs, timelines, and reporting formats
- –Broad portfolio can slow niche single-protocol support compared with specialized vendors
Best for: Sponsors needing integrated development execution from preclinical through clinical stages
Charles River Laboratories
enterprise_vendorDelivers preclinical safety assessment and translational services that support pharmaceutical and biotechnology development through regulated studies.
QA-driven, end-to-end study execution with integrated bioanalytical and in vivo capabilities
Charles River Laboratories delivers end-to-end CRO and lab services with a strong operational footprint across study execution, bioanalytical support, and data generation. The company supports regulated research workflows for drug discovery through clinical and nonclinical phases using established QA and documented processes.
Cro Pharma Services buyers typically engage Charles River for specialized assays, in vivo model work, and cross-functional study coordination that ties experimental design to measurable endpoints. Its distinct advantage is the ability to cover multiple disciplines in one vendor workflow, reducing handoffs between model, assay, and reporting teams.
- +Integrated nonclinical and bioanalytical execution under one study governance model.
- +Wide in vivo model capabilities with controlled study management.
- +Experienced CRO operations for regulated documentation and audit-ready outputs.
- +Cross-discipline coordination from experimental design through endpoint reporting.
- –Study timelines can be sensitive to CRO capacity and site scheduling.
- –Complex multi-site studies may increase coordination overhead for sponsors.
- –Assay optimization workload can shift depending on endpoint specificity.
Best for: Sponsors needing multi-discipline CRO delivery across in vivo and bioanalytical workstreams
Labcorp Drug Development
enterprise_vendorProvides clinical trial execution, bioanalytical testing, and pharmacology services for pharmaceutical and biotechnology sponsors.
Integrated chain-of-custody sample management paired with centralized bioanalytical assay execution
Labcorp Drug Development stands out for integrating centralized clinical laboratory testing with end-to-end study support across phases. The service set covers sample collection oversight, chain of custody, and high-throughput bioanalytical work for regulated drug programs.
Labcorp also supports pharmacology deliverables such as drug concentration measurement and metabolite profiling using established analytical methods. Teams get managed coordination of lab operations designed to align with clinical site workflows and data reporting needs.
- +Centralized drug development lab workflows reduce cross-vendor handoffs
- +Strong bioanalytical capabilities support pharmacokinetic and metabolite studies
- +Chain-of-custody processes help maintain sample integrity and compliance
- +Operational coordination supports clinical site sampling and shipping
- –Program setup can require detailed upfront requirements from sponsors
- –Service scope may feel broad for teams needing narrowly focused testing
- –Turnaround depends on study volume and lab scheduling constraints
- –Long documentation paths can slow change requests mid-study
Best for: Sponsors needing managed clinical lab operations plus regulated bioanalytical testing
Veeva Consulting
otherDelivers implementation and operational consulting for regulated life sciences workflows that support clinical and quality processes.
Veeva CRM and Vault-centric implementation delivery with compliance-minded configuration governance
Veeva Consulting stands out by focusing on regulated life sciences workflows around Veeva’s Commercial and Clinical technology stack. Cro Pharma Services fit benefits from implementation and optimization of data, processes, and user adoption for sales, medical, and study operations.
Delivery typically emphasizes configuration, integration guidance, and change management to connect target-state processes across teams and systems. Governance, documentation, and compliance-minded rollout planning align well with pharma needs for traceable execution and controlled release cycles.
- +Deep expertise aligning business processes with Veeva Commercial and Clinical modules
- +Structured implementation approach for controlled rollouts and traceable change management
- +Integration support to connect CRM, data sources, and enterprise systems reliably
- +Strong focus on user adoption through enablement and workflow standardization
- –Best results require clear process ownership from Cro Pharma Services stakeholders
- –Complex integrations can extend timelines when upstream systems are not ready
- –Customization demands rigorous governance to avoid configuration sprawl
- –Less suited to teams needing platform-agnostic consulting across unrelated vendors
Best for: Pharma teams implementing Veeva workflows with integration and adoption support
Medpace
enterprise_vendorProvides clinical development and trial management services for biotechnology and pharmaceutical companies across phases.
Centralized study execution model spanning site management, monitoring, and documentation
Medpace stands out for global clinical operations delivery across multiple therapeutic areas and study phases. Core capabilities include site management, investigator start-up support, patient recruitment logistics, and end-to-end study execution for sponsor-led trials.
Cro Pharma Services teams can align Medpace for complex protocol delivery, vendor coordination, and quality-oriented documentation workflows. Strong operational focus suits programs needing consistent cross-region execution and robust monitoring discipline.
- +Global clinical execution with standardized site management practices
- +Strong monitoring and documentation workflows for sponsor oversight
- +Therapeutic-area breadth supporting diverse protocol requirements
- +Operational support for investigator start-up and study scaling
- –Primarily clinical execution strength with limited nonclinical services
- –Complex studies may require more intensive sponsor alignment effort
- –Less suitable for very small trials needing minimal coordination
Best for: Sponsors needing global, quality-driven clinical operations support
Conclusion
After evaluating 10 biotechnology pharmaceuticals, IQVIA stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
How to Choose the Right cro pharma services
CRO pharma services combine clinical operations delivery, data and reporting workflows, and governance support across global studies. This guide covers IQVIA, ICON, Parexel, CROMSOURCE, Syneos Health, Wuxi AppTec, Charles River Laboratories, Labcorp Drug Development, Veeva Consulting, and Medpace.
The provider strengths differ by operating model, including real-world evidence execution with structured pipelines at IQVIA, integrated clinical operations plus data management under one delivery structure at ICON, and centralized quality and regulatory document workflows at Parexel.
CRO pharma services for trial execution, study data delivery, and governance-ready documentation workflows
CRO pharma services deliver end-to-end or component clinical and nonclinical workstreams with study execution controls, site and vendor coordination, and sponsor-facing reporting. IQVIA supports analytics-driven real-world evidence execution with operational study support, while ICON pairs global clinical operations with data management execution under one delivery structure.
Across large programs, Parexel centers trial delivery on centralized quality and regulatory documentation workflows, which reduces the number of handoffs required for audit-ready outputs. For sponsors that need drug development lab operations tied to chain-of-custody sample management, Labcorp Drug Development runs centralized bioanalytical assay execution alongside regulated clinical lab workflows. Some providers also focus on the implementation layer of CRO workflows, with Veeva Consulting delivering compliance-minded configuration governance for Veeva CRM and Vault-centered processes.
CRO pharma services capabilities that control execution, data delivery, and governance
CRO pharma services decide study throughput through clinical operations controls, data management execution, and sponsor-facing reporting cadence. These controls show up as coordinated site and vendor workflows across monitoring, data handoffs, and document readiness.
Integration depth determines how quickly changes propagate during late-stage protocol adjustments. IQVIA’s real-world evidence execution pairs structured data pipelines with operational study support, while ICON bundles global clinical operations with data management execution under one delivery structure.
Integrated clinical operations plus data management
ICON supports disciplined global clinical operations with consistent site and vendor coordination, and pairs that with data management execution under one delivery structure. Parexel centers trial delivery on centralized quality and regulatory documentation workflows that reduce handoffs for audit-ready outputs.
Real-world evidence delivery with structured data pipelines
IQVIA delivers real-world evidence execution with integrated healthcare data, analytics, and operational study support tied to structured data pipelines for pharma decisions. This model emphasizes governance around operational study progress and data-backed decisions.
Quality and regulatory documentation workflows
Parexel runs centralized quality and regulatory-facing document workflows across global study execution, which reduces document friction across planning, conduct, and deliverables. IQVIA also pairs operational governance with study execution support for sponsor-facing reporting.
Drug development lab operations with chain-of-custody workflows
Labcorp Drug Development combines chain-of-custody sample management with centralized bioanalytical assay execution. This reduces cross-vendor handoffs for pharmacokinetic and metabolite studies.
In vivo and bioanalytical nonclinical execution under one governance model
Charles River Laboratories supports QA-driven end-to-end study execution with integrated bioanalytical and in vivo workstreams. This structure helps sponsors manage multi-discipline nonclinical timelines under controlled study management.
Veeva workflow implementation with configuration governance
Veeva Consulting delivers Veeva CRM and Vault-centric implementation delivery with compliance-minded configuration governance. It is suited for teams that need controlled rollouts and traceable change management aligned to Veeva Commercial and Clinical modules.
How to choose CRO pharma services based on operating model, control depth, and integration needs
Selection should start with the operating model that matches the study shape and internal sponsor capacity. IQVIA and ICON align with analytics-driven or operations-led global execution models, while Parexel prioritizes centralized quality and regulatory documentation workflows for large programs.
Next, map governance requirements to the provider’s change-control behavior across late-stage adjustments. Providers that require formal coordination or add overhead for governance change requests, including IQVIA, ICON, and Parexel, still fit well when sponsor decision timelines and governance roles are clearly defined.
Match the delivery structure to study ownership and change cadence
ICON fits sponsors that need global clinical operations plus data management execution under one delivery structure, because it reduces coordination across separate vendors for clinical and data workstreams. IQVIA fits sponsors running analytics-driven real-world evidence programs that require operational study support tied to structured data pipelines.
Confirm governance and documentation workflow centralization
Parexel is a strong match for large programs that need centralized quality and regulatory documentation workflows that produce audit-ready outputs with fewer handoffs. IQVIA and ICON also provide operational governance support, but governance coordination can slow late-stage changes if sponsor roles are not aligned.
Align lab or nonclinical needs to the provider’s integrated execution scope
Labcorp Drug Development suits pharmacokinetic and metabolite programs that require regulated bioanalytical assay execution paired with chain-of-custody sample management. Charles River Laboratories suits sponsors that need QA-driven end-to-end nonclinical studies with integrated bioanalytical and in vivo capabilities under one study governance model.
Select for integration and configuration control when Veeva systems are in scope
Veeva Consulting fits teams implementing Veeva CRM and Vault-centered workflows that require compliance-minded configuration governance and traceable change management. Complex integrations that depend on upstream readiness can extend timelines, which makes internal process ownership a key decision variable.
Validate execution fit for global scale versus limited-scope studies
Syneos Health supports integrated clinical operations tied to commercialization and medical affairs execution, which can add overhead for rapid iterative change requests in smaller or narrow studies. Medpace concentrates on global clinical execution with standardized site management, monitoring, and documentation workflows, but it emphasizes clinical execution strength over nonclinical scope.
Who CRO pharma services fit best across clinical, data, lab, and implementation workstreams
CRO pharma services fit sponsors that need controlled execution across global sites, consistent data delivery, and governance-ready documentation. The best match depends on whether the primary bottleneck sits in clinical operations, data management, regulated lab workflows, or workflow implementation.
IQVIA, ICON, and Parexel cover many global sponsor needs, with IQVIA emphasizing real-world evidence execution and analytics-driven decisions, ICON emphasizing integrated operations plus data delivery, and Parexel emphasizing centralized quality and regulatory documentation workflows.
Global pharma programs running real-world evidence studies
IQVIA supports real-world evidence execution with integrated healthcare data, analytics, and operational study support backed by structured data pipelines for pharma decisions.
Sponsors that want unified clinical operations and data delivery
ICON pairs global clinical operations with data management execution under one delivery structure, which reduces cross-vendor handoffs between monitoring and data workflows.
Large programs that require audit-ready regulatory documentation outputs
Parexel centralizes quality and regulatory documentation workflows across global trial delivery, which reduces the number of handoffs required for audit-ready outputs.
Sponsors that need regulated bioanalytical testing plus chain-of-custody sample management
Labcorp Drug Development combines chain-of-custody sample management with centralized bioanalytical assay execution for pharmacokinetic and metabolite studies.
Pharma teams implementing Veeva CRM and Vault workflows
Veeva Consulting delivers Veeva CRM and Vault-centric implementation with compliance-minded configuration governance and traceable change management.
Common pitfalls when buying CRO pharma services
Buying mistakes often come from misaligned governance roles, unclear decision timelines, and overestimating flexibility during late-stage changes. Providers that emphasize centralized quality, operations governance, or configuration governance still require clear sponsor coordination for smooth adjustments.
Another recurring issue is selecting a vendor whose integrated scope does not cover the regulated lab or nonclinical workstream. Lab-centric or nonclinical studies can fail to meet timelines when sample management, bioanalytical execution, or in vivo workstreams are split across unrelated partners.
Choosing a provider without aligning sponsor governance roles to the provider’s change-control behavior
IQVIA, ICON, and Parexel can slow late-stage adjustments when governance coordination is unclear, so sponsor stakeholders should define decision timelines before changes enter execution.
Treating data delivery as a separate workstream from clinical operations coordination
ICON is structured to pair clinical operations with data management under one delivery structure, while fragmented models add coordination overhead for global site and vendor workflows.
Under-scoping regulated lab workflows and chain-of-custody requirements
Labcorp Drug Development pairs chain-of-custody sample management with centralized bioanalytical assay execution, so sponsors should include both requirements when bioanalytical testing is mission critical.
Assuming nonclinical needs are covered by a primarily clinical operations CRO
Medpace focuses on clinical execution strength, while Charles River Laboratories provides QA-driven end-to-end nonclinical execution with integrated bioanalytical and in vivo capabilities.
Selecting a Veeva implementation partner without confirming upstream system readiness
Veeva Consulting can extend timelines when upstream systems are not ready, so sponsors should ensure internal process ownership and integration readiness before configuration work starts.
How We Selected and Ranked These Providers
We evaluated IQVIA, ICON, and Parexel against CRO pharma services cards that score overall capability, feature depth, ease of delivery, and value. Features drove 40% of the ranking because integration breadth across trial execution, data delivery, and governance-ready outputs directly affects study control.
Ease and value each drove 30% because global coordination overhead changes whether sponsor teams can act quickly during protocol and operational adjustments. IQVIA stood apart through analytics-driven real-world evidence execution tied to structured data pipelines and operational study support, which directly connects data-backed decisions to day-to-day governance.
Frequently Asked Questions About cro pharma services
How do IQVIA and ICON differ in operational delivery for global CRO programs?
Which provider fits sponsors that need end-to-end regulatory-ready document workflows, not only monitoring?
When a program needs study execution with strong sponsor visibility into deliverables and progress, which option is most aligned?
How do Veeva Consulting and ICON handle onboarding and configuration changes during a study?
What integration expectations should sponsors set when connecting CRO data models across vendors?
Which provider is better for high-throughput regulated lab work with chain-of-custody controls?
How do Charles River Laboratories and Wuxi AppTec differ when the deliverables span preclinical through clinical material support?
Which provider aligns best with global site management and investigator start-up for sponsor-led trials?
How do IQVIA and Parexel handle auditability and governance signals across complex study stages?
What extensibility patterns show up most often when teams integrate CRO operations into existing enterprise systems?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→In this category
Biotechnology Pharmaceuticals alternatives
See side-by-side comparisons of biotechnology pharmaceuticals tools and pick the right one for your stack.
Compare biotechnology pharmaceuticals tools→